ABBOTT GMBH & AMP CO KG has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Taiwan and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are FRANKLIN RICHARD, BRITISH BIOTECH PHARM and DUQUESNE UNIV OF THE HOLY GHOST.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 7 | |
#2 | Republic of Korea | 6 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Amberg Wilhelm | 5 |
#2 | Behl Berthold | 5 |
#3 | Ochse Michael | 5 |
#4 | Lange Udo | 5 |
#5 | Hornberger Wilfried | 4 |
#6 | Pohlki Frauke | 4 |
#7 | Hutchins Charles W | 3 |
#8 | Mezler Mario | 3 |
#9 | Kling Andreas | 2 |
#10 | Lao Yanbin | 2 |
Publication | Filing date | Title |
---|---|---|
TW201210582A | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | |
TW201211030A | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy | |
TW201211031A | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy | |
KR20120016639A | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |